share_log

B of A Securities Downgrades IGM Biosciences to Neutral, Announces $8 Price Target

B of A Securities Downgrades IGM Biosciences to Neutral, Announces $8 Price Target

A股银行将IGM Biosciences的评级下调至中性,宣布目标股价为8美元
Benzinga ·  2023/12/15 08:39

B of A Securities analyst Geoff Meacham downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Neutral and announces $8 price target.

Bof A Securities分析师杰夫·米查姆将IGM Biosciences(纳斯达克股票代码:IGMS)的评级从买入下调至中性,并宣布了8美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发